BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8460348)

  • 1. Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients.
    Donnelly JP; Muus P; Horrevorts AM; Sauerwein RW; De Pauw BE
    Scand J Infect Dis; 1993; 25(1):43-50. PubMed ID: 8460348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients.
    Donnelly JP; Muus P; Schattenberg A; De Witte T; Horrevorts A; DePauw BE
    Bone Marrow Transplant; 1992 Jun; 9(6):409-13. PubMed ID: 1628123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies.
    Ruescher TJ; Sodeifi A; Scrivani SJ; Kaban LB; Sonis ST
    Cancer; 1998 Jun; 82(11):2275-81. PubMed ID: 9610710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Graber CJ; de Almeida KN; Atkinson JC; Javaheri D; Fukuda CD; Gill VJ; Barrett AJ; Bennett JE
    Bone Marrow Transplant; 2001 Mar; 27(5):537-42. PubMed ID: 11313689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
    Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment.
    Yuen KY; Woo PC; Hui CH; Luk WK; Chen FE; Lie AK; Liang R
    Bone Marrow Transplant; 1998 Jun; 21(11):1137-43. PubMed ID: 9645577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study.
    Engelhard D; Elishoov H; Or R; Naparstek E; Nagler A; Strauss N; Cividalli G; Aker M; Ramu N; Simhon A
    Bone Marrow Transplant; 1995 Oct; 16(4):565-70. PubMed ID: 8528173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile mucositis in haematopoietic SCT recipients.
    van der Velden WJ; Blijlevens NM; Feuth T; Donnelly JP
    Bone Marrow Transplant; 2009 Jan; 43(1):55-60. PubMed ID: 18762766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute group A streptococcal pharyngotonsillitis.
    Orrling A; Kamme C; Stjernquist-Desatnik A
    Scand J Infect Dis; 2005; 37(6-7):429-35. PubMed ID: 16012002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients.
    Blijlevens NM; Donnelly JP; DePauw BE
    Bone Marrow Transplant; 2005 Oct; 36(8):703-7. PubMed ID: 16062174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent.
    Muus P; Donnelly P; Schattenberg A; Linssen P; Minderman H; Dompeling E; de Witte T
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):47-52. PubMed ID: 8290971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation.
    Schots R; Van Riet I; Othman TB; Trullemans F; De Waele M; Van Camp B; Kaufman L
    Bone Marrow Transplant; 2002 Oct; 30(7):441-6. PubMed ID: 12368956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
    Marron A; Carratalà J; González-Barca E; Fernández-Sevilla A; Alcaide F; Gudiol F
    Clin Infect Dis; 2000 Nov; 31(5):1126-30. PubMed ID: 11073739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients.
    Villablanca JG; Steiner M; Kersey J; Ramsay NK; Ferrieri P; Haake R; Weisdorf D
    Bone Marrow Transplant; 1990 Jun; 5(6):387-93. PubMed ID: 2369679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation.
    Anderson PM; Ramsay NK; Shu XO; Rydholm N; Rogosheske J; Nicklow R; Weisdorf DJ; Skubitz KM
    Bone Marrow Transplant; 1998 Aug; 22(4):339-44. PubMed ID: 9722068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients.
    De Pauw BE; Donnelly JP; De Witte T; Nováková IR; Schattenberg A
    Bone Marrow Transplant; 1990 Mar; 5(3):179-82. PubMed ID: 2184908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of oral doses of clindamycin and erythromycin in the prevention of bacteraemia.
    Aitken C; Cannell H; Sefton AM; Kerawala C; Seymour A; Murphy M; Whiley RA; Williams JD
    Br Dent J; 1995 Jun; 178(11):418-22. PubMed ID: 7599015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
    Avery R; Kalaycio M; Pohlman B; Sobecks R; Kuczkowski E; Andresen S; Mossad S; Shamp J; Curtis J; Kosar J; Sands K; Serafin M; Bolwell B
    Bone Marrow Transplant; 2005 Mar; 35(5):497-9. PubMed ID: 15640812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clarithromycin on oral mucositis in bone marrow transplant recipients.
    Yuen KY; Woo PC; Tai JW; Lie AK; Luk J; Liang R
    Haematologica; 2001 May; 86(5):554-5. PubMed ID: 11410428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.